Back to Peptides
Crystagen
Immune ModulationCrystagen is a thymic-derived peptide bioregulator that modulates immune function, supports thymic repair, and enhances lymphocyte output. It is administered orally and has been shown in Eastern European research to improve immune performance in aging and immunosuppressed individuals.
Administration
Oral
capsules capsule/tablet
Daily Range
1–3 capsules Oral
Daily
Standard Dose
2 capsules
Cycle
4–8 weeks
then reassess
Crystagenimmune peptidethymus bioregulatororal peptidecytogen
Dosing Guide
Administered at 100–200 μg per day in studies. Clinical use is not authorized.
Standard / Gradual Approach
standardPhaseDose
Week 11000 mcg (1 mg)
Week 21500 mcg (1.5 mg)
Weeks 3–122000 mcg (2 mg)
Protocol Summary
Oral: Daily · Dose range 1–3 capsules with gradual titration
Cycle Length: 4–8 weeks typical; reassess before extending
Frequency & Cycling
Oral
Typical course: 10–30 days of daily dosing. Repeat up to 2–3x per year for immune maintenance.
💊 Quick Start
Starting Dose
1000 mcg (1 mg) (15 units (0.15 mL))
Maintenance Dose
2000 mcg (2 mg) (30 units (0.30 mL))
Potential Benefits & Use Cases
Crystagen is a thymic bioregulatory peptide not approved for clinical use. For research only.
May support immune system modulation through thymic bioregulatory peptide mechanisms (preclinical)
Preserves thymic cortex-medulla division and stimulates thymocyte proliferation in irradiated rats (preclinical)
Normalized immunogram in 82% of elderly patients — increased CD3+ and CD4+ cells, normalized CD4+/CD8+ ratio (limited human data)
Clinical data Strong preclinical Limited data
Mechanism of Action
→Normalizes thymus-derived peptide signaling pathways
→Stimulates lymphocyte differentiation and cytokine balance
→Restores immune regulatory gene expression in aged individuals
Lifestyle & Optimization
timing
Consistent daily dosing.
diet
Balanced nutrient-dense diet. Stay hydrated.
exercise
Regular physical activity.
sleep
Adequate sleep (7–9 hours). Manage stress.
Peptide Research & Preclinical Studies
Evidence-Based Research Findings
Study TitleType
Side Effects & Safety
🧬
Bioavailability & Absorption
SubQ Injection
Not applicable to this compound
Oral Administration
Formulated for oral delivery via capsule; effective for gene modulation at low doses
Half-Life
Not published; effects persist through gene expression regulation
Degradation
Metabolized via standard proteolytic peptide pathways
Tissue Specificity
Thymus, lymph nodes, and peripheral immune cells
⚗️
Peptide Details
Molecular Weight
467.57
Formula
C23H37N5O6
Sequence
Ala-Glu-Asp-Gly
⚖️
Legal Status & Regulatory
RegionStatus
FDANot Approved
EUNot Approved
AustraliaNot Approved
CanadaNot Approved
Storage Instructions
Lyophilized (Powder)
refrigerate at 4 °C (39.2 °F) or freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 4 °C (39.2 °F) for up to 30 days
Reconstituted (Mixed)
Refrigerate at 4 °C (39.2 °F); stable for approximately 30 days